|
|
 |
Record Abstract Submissions Reflect Global Priorities
11 March 2005
AIDS researchers submitted 2,060 abstracts for presentation IAS 2005 Conference.
One-fifth of the abstracts focus on treatment and care in resource-constrained settings, merging well with the conference’s commitment to present scientific information anchored in the reality of the global HIV experience. The other categories with the most submissions include treatment strategies, transmission of HIV and co-infections.
Abstract submissions came from 114 countries in all the world’s regions. The top five submitting countries were USA (392), Brazil (141), India (126), Spain (124), and Italy (117) with six more countries submitting over 50 abstracts each (Nigeria, Argentina, United Kingdom, France, Canada, and South Africa).
The submissions were a nearly 10% increase over the 1,888 received for the 2nd IAS Conference on HIV Pathogenesis and Treatment held in Paris in July 2003. Of those received in 2003, 188 (10%) were selected for oral presentations and 986 (55%) for poster presentations.
After being scored blindly by over 250 reviewers, abstracts will be selected for oral and poster presentation at the Marathon Meeting in early April. In addition to abstract-driven sessions, the Conference will feature daily plenary sessions, fora and debates.
This year nearly 100 experienced authors have helped inexperienced abstract submitters improve the quality of their abstracts. By leveraging the experience of past abstract submitters, the Mentor Scheme aims to increase the number of accepted abstracts from young investigators and scientists working in resource-limited setting.
IAS 2005 programme is centered on basic, clinical and prevention sciences. Basic sciences will focus on HIV virology and immunology, and AIDS vaccine research. Clinical sciences will cover a breadth of issues from treatment in resource-limited settings to state-of-the-art and high technology topics. Prevention sciences will cover epidemiology, science of behaviour change and prevention research including vaccines, microbicides, chemoprophylaxis and other prevention methods.
IAS 2005 promises to build on the important role of the 2nd IAS Conference on HIV Pathogenesis and Treatment in Paris in 2003 where presentations included new data on initiation and complications of antiretroviral therapy, HIV dug resistance, salvage therapy, preventing mother-to-child transmission, and investigational drugs.
|
|
|
|